Global Specialty Drug Distribution Market is segmented on the basis of product type, distribution channel, and region. Specialty drugs are high-cost prescription medications used to treat complex, chronic conditions like cancer, rheumatoid arthritis and multiple sclerosis. They often require special handling, storage and administration, and involve a significant degree of patient education, monitoring and management. Many of these drugs also require injection or infusion.
Specialty drugs are the product of a wave of relatively recent scientific developments, made possible, in large part due to the sequencing of the human genome and resulting genomic science. A large proportion of specialty drugs are biologics. These are “innovator” drugs, developed under patent by one drug company. Rather than being made chemically, they are made with living cells. Subsequent entry biologics (SEBs) is a biologic drug that are produced using similar leading-edge genetic science as the reference drug.
Specialty drugs might be covered through either medical or prescription drug insurance. Specialty drugs are designed to improve operational efficiency and enhance patient care.Due to the complexity associated with administration or managing side-effects, many of the drug manufacturers provide patient assistance programs to help individuals taking these drugs.
Global Specialty Drug Distribution Market is classified, by product type, into Oncology, Rheumatoid Arthritis, Multiple Sclerosis, Hemophilia, and others. Global Specialty Drug Distribution Market is classified, by distribution channel, into Retail, Home Health, Clinics, and Pharmacies. Global Specialty Drug Distribution Market is segmented, geographically into North America, Europe (Eastern Europe, Western Europe), Asia Pacific, Latin America, Middle East and Africa.
North America held the largest market share of the global Specialty Drug Distribution Market and will lead the market in future. This is owing to increased use of specialty drugs to treat chronic diseases, better healthcare reforms, and better distribution facilities. Europe is leisurely gaining share in the specialty drug distribution market. The diverse geographical landscape in Europe does serve as a major challenge in having an efficient logistics and distribution network.
The highest growth is expected to be witnessed in Asia Pacific region, in countries such as China, India, and Australia. This is due to the innovative distribution facilities and improving infrastructure. Global Specialty Drug Distribution Industry key players are, Amerisource, Mckesson, Cardinal Health, PHOENIX, Medipal Holdings, Alliance Healthcare, Celesio, Sinopharm, Accredo, Shanghai Pharma, Anda, Jointown, Max Pharma, and Avella.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Specialty Drug Distribution in these regions, from 2013 to 2025 (forecast), covering
• North America
• Southeast Asia
Global Specialty Drug Distribution market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• Cardinal Health
• Medipal Holdings
• Alliance Healthcare
• Shanghai Pharma
• Max Pharma
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• Rheumatoid Arthritis
• Multiple Sclerosis
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
• Home Health
Research Support Specialist, USA